2.38
price up icon3.03%   0.07
after-market 시간 외 거래: 2.34 -0.04 -1.68%
loading
전일 마감가:
$2.31
열려 있는:
$2.3
하루 거래량:
1.15M
Relative Volume:
1.30
시가총액:
$253.04M
수익:
$45.44M
순이익/손실:
$-35.43M
주가수익비율:
-7.00
EPS:
-0.34
순현금흐름:
$-25.39M
1주 성능:
+8.68%
1개월 성능:
-18.21%
6개월 성능:
-32.96%
1년 성능:
-48.82%
1일 변동 폭
Value
$2.24
$2.40
1주일 범위
Value
$2.18
$2.40
52주 변동 폭
Value
$2.10
$5.26

맥스사이트 Stock (MXCT) Company Profile

Name
명칭
Maxcyte Inc
Name
전화
301-517-5556
Name
주소
9713 KEY WEST AVENUE,, ROCKVILLE
Name
직원
114
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
MXCT's Discussions on Twitter

MXCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
MXCT
Maxcyte Inc
2.38 232.84M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
133.58 228.44B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
105.26 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
382.64 143.93B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
82.98 103.43B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.22 43.99B 5.54B 4.18B 623.10M 7.00

맥스사이트 Stock (MXCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-29 개시 Craig Hallum Buy
2021-10-15 재개 Cowen Outperform
2021-08-24 개시 BTIG Research Buy
2021-08-24 개시 Cowen Outperform
2021-08-24 개시 Stephens Overweight
2021-08-24 개시 Stifel Buy
2021-08-24 개시 Wedbush Outperform
2021-08-24 개시 William Blair Outperform
모두보기

맥스사이트 주식(MXCT)의 최신 뉴스

pulisher
May 31, 2025

MaxCyte (NASDAQ:MXCT) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 38,782 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 31, 2025
pulisher
May 29, 2025

MaxCyte Announces Change in Voting Rights Structure - TipRanks

May 29, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Buys 84,105 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 27, 2025
pulisher
May 23, 2025

MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks

May 23, 2025
pulisher
May 23, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

May 23, 2025
pulisher
May 23, 2025

BlackRock Increases Stake in MaxCyte, Boosting Voting Rights - TipRanks

May 23, 2025
pulisher
May 19, 2025

BlackRock Increases Stake in MaxCyte to 7.65% - TipRanks

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $177,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 18, 2025
pulisher
May 16, 2025

MaxCyte Announces Change in Major Shareholder Holdings - TipRanks

May 16, 2025
pulisher
May 16, 2025

MaxCyte, Inc. (MXCT): A Bull Case Theory - MSN

May 16, 2025
pulisher
May 15, 2025

MaxCyte Inc (MXCT): Be Patient, You Will Learn - Stocksregister

May 15, 2025
pulisher
May 13, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

MaxCyte’s Earnings Call: Navigating Challenges and Opportunities - TipRanks

May 12, 2025
pulisher
May 12, 2025

William Blair Predicts MaxCyte’s Q2 Earnings (NASDAQ:MXCT) - Defense World

May 12, 2025
pulisher
May 11, 2025

Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 11, 2025
pulisher
May 09, 2025

MaxCyte Files Form 10-Q for Q1 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

BTIG cuts MaxCyte stock price target to $5, maintains Buy rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: MaxCyte Q1 2025 beats revenue forecast, stock reacts - Investing.com

May 08, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Boosts Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 08, 2025
pulisher
May 08, 2025

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - The Manila Times

May 08, 2025
pulisher
May 08, 2025

MaxCyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 07, 2025

MaxCyte Reports Q1 2025 Financial Results Amid Revenue Dip - TipRanks

May 07, 2025
pulisher
May 07, 2025

MaxCyte reports Q1 EPS (10c), consensus (10c) - TipRanks

May 07, 2025
pulisher
May 07, 2025

Financial Fitness Check: Examining MaxCyte Inc (MXCT)’s Key Ratios - DWinneX

May 07, 2025
pulisher
May 06, 2025

A Look at MaxCyte's Upcoming Earnings Report - Nasdaq

May 06, 2025
pulisher
May 05, 2025

MaxCyte Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Has $204,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 05, 2025
pulisher
May 05, 2025

MaxCyte (MXCT) to Release Quarterly Earnings on Wednesday - Defense World

May 05, 2025
pulisher
May 03, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Position Trimmed by Legal & General Group Plc - Defense World

May 03, 2025
pulisher
May 02, 2025

MaxCyte Expands Stock Capital with New Share Issuance - TipRanks

May 02, 2025
pulisher
May 01, 2025

Upward Trajectory: MaxCyte Inc (MXCT) Posts a Slidee, Closing at 2.84 - DWinneX

May 01, 2025
pulisher
May 01, 2025

A stock that deserves closer examination: MaxCyte Inc (MXCT) - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Has $1.17 Million Stock Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Acquires 91,100 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - The AM Reporter

Apr 30, 2025
pulisher
Apr 28, 2025

MaxCyte Announces AIM Delisting to Focus on NASDAQ - TipRanks

Apr 28, 2025
pulisher
Apr 23, 2025

MaxCyte Inc (MXCT) requires closer examination - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

BlackRock Adjusts Stake in MaxCyte, Inc. - TipRanks

Apr 22, 2025
pulisher
Apr 16, 2025

Vanguard Group Inc. Sells 345,587 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Cooley Advises Cell Therapy Biz On London Market Exit - Law360

Apr 15, 2025
pulisher
Apr 15, 2025

MaxCyte intends to delist from London's AIM to enhance liquidity - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

MaxCyte to Delist from AIM, Focus on Nasdaq - TipRanks

Apr 15, 2025
pulisher
Apr 12, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Stock Holdings Lifted by American Century Companies Inc. - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

MaxCyte stock plunges to 52-week low of $2.25 amid market challenges By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

MaxCyte stock plunges to 52-week low of $2.25 amid market challenges - Investing.com India

Apr 10, 2025

맥스사이트 (MXCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$325.03
price up icon 0.36%
medical_devices STE
$245.21
price up icon 0.09%
medical_devices SNN
$28.96
price up icon 0.49%
$70.54
price down icon 1.38%
$85.80
price up icon 1.11%
medical_devices EW
$78.22
price up icon 0.63%
자본화:     |  볼륨(24시간):